Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: A Pragmatic Multicentre Randomised Placebo Controlled Trial

D. B. Price, S. Cotton, S. Fielding, N. McMeekin, P. Barnes, A. Briggs, G. Burns, R. Chaudhuri, H. Chrystyn, L. Davies, A. De Soyza, S. Gompertz, J. Haughney, A. Lee, A. Morice, J. Norrie, A. Sullivan, A. Wilson, G. Devereux

Research output: Contribution to journalAbstract

11 Downloads (Pure)
Original languageEnglish
Article numberA7709
Number of pages2
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume197
Publication statusPublished - May 2018
EventAmerican Thoracic Society 2018 International Conference - San Diego Convention Center, San Diego, United States
Duration: 18 May 201823 May 2018

Cite this

Price, D. B., Cotton, S., Fielding, S., McMeekin, N., Barnes, P., Briggs, A., Burns, G., Chaudhuri, R., Chrystyn, H., Davies, L., De Soyza, A., Gompertz, S., Haughney, J., Lee, A., Morice, A., Norrie, J., Sullivan, A., Wilson, A., & Devereux, G. (2018). Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: A Pragmatic Multicentre Randomised Placebo Controlled Trial. American Journal of Respiratory and Critical Care Medicine, 197, [A7709]. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A7709